mAChRs agonists(Muscarinic acetylcholine receptor agonists), α-adrenergic receptor antagonists(Alpha adrenergic receptor antagonists), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists)

Therapeutic Areas

Eye Diseases

Active Indication

Glaucoma

Inactive Indication-

Originator Organization

Moscow Endocrine Plant

Active Organization

Moscow Endocrine Plant

Inactive Organization-

Drug Highest PhaseApproved

First Approval Date

RU (01 May 2006),

Glaucoma

Regulation-

Structure/Sequence

Molecular FormulaC28H42ClN5O7

InChIKeyLRVWAIHIGUVUNO-ZCVIPUSMSA-N

CAS Registry392656-69-8

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	S01EB51	-

R&D Status

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Glaucoma	RU	Moscow Endocrine Plant	01 May 2006

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis